The AGO3 antibody, biotin conjugated, is a specialized immunological reagent designed for detecting the Argonaute 3 (AGO3) protein, a critical component of RNA-induced silencing complexes (RISCs) involved in post-transcriptional gene regulation. Biotin conjugation enhances the antibody’s utility by enabling high-affinity binding to streptavidin/avidin, facilitating signal amplification and versatile detection methods in assays like ELISA, immunoprecipitation, and flow cytometry .
Biotinylated AGO3 antibodies consist of:
Antigen-specific region: Targets AGO3, a 87 kDa protein (UniProt: Q9H9G7) that binds small RNAs (e.g., siRNA, miRNA) to mediate RNA interference .
Biotin conjugation: Covalently attached biotin molecules enable binding to streptavidin, which is often linked to enzymes (e.g., HRP, alkaline phosphatase) or fluorescent dyes for detection .
Component | Role |
---|---|
AGO3-binding domain | Recognizes AGO3 epitopes (e.g., recombinant full-length AGO3 protein) |
Biotin tag | Facilitates detection via streptavidin-linked reporters |
Biotin-conjugated AGO3 antibodies are employed in:
ELISA: Quantitative analysis of AGO3 levels in lysates or serum .
Immunoprecipitation (IP): Isolation of AGO3-associated RNAs or proteins (e.g., decapping complexes) .
Flow Cytometry: Detection of AGO3 in intracellular compartments or on cell surfaces .
Immunofluorescence: Localization of AGO3 in fixed cells or tissues .
ELISA: Coat plates with AGO3 antigen. Detect bound biotinylated antibody using streptavidin-HRP and chromogenic substrate .
IP: Use streptavidin-coated beads to pull down AGO3 complexes, followed by RNA/protein analysis .
Alu RNA stabilization: AGO3 interacts with Alu retrotransposons (e.g., DR2 Alu) to protect them from degradation, enabling their regulatory roles in gene expression .
mRNA decapping: AGO3 associates with the decapping complex (e.g., EDC4, DCP2) to promote 5’ cap removal and exonuclease-mediated mRNA degradation .
Method: Biotin-labeled RNAs immunoprecipitated with AGO3-specific antibodies confirmed RNA binding and stability .
Retinoic acid (atRA) downregulates target mRNAs (e.g., Nanog, Phlda1) via AGO3-dependent mechanisms, as shown by siRNA knockdown experiments .
Cross-reactivity: Ensure antibodies are cross-adsorbed to minimize non-specific binding (e.g., human vs. mouse reactivity) .
Protocol Complexity: Biotin-streptavidin systems require additional steps (e.g., streptavidin-HRP incubation) compared to directly conjugated enzymes .
Cost: Higher expenses due to biotin conjugation and streptavidin reagents .